BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 12, 2017
View Archived Issues
Juno Therapeutics enters various agreements for multiple myeloma program
Read More
FDA expands orphan drug designation for patisiran
Read More
FDA grants orphan drug designation to PLX-100 for the treatment of neuronal ceroid lipofuscinoses
Read More
Janssen submits sNDA in U.S. for two new Xarelto indications
Read More
CRISPR Therapeutics applies to conduct clinical trial of CTX-001
Read More
Semi-synthetic organism encodes and retrieves increased genetic information
Read More
HMBD-004, a bispecific antibody targeting CD47 and CD33, shows promise for AML
Read More
Phase III IMmotion151 trial meets co-primary endpoints
Read More
FDA accepts BLA for galcanezumab for prevention of migraine
Read More
FDA accepts sBLA for Keytruda, grants priority review
Read More
BioVie's BIV-201 given FDA fast track designation
Read More
Topline results reported from phase II study of ARGX-113 in myasthenia gravis
Read More
Harpoon Therapeutics patents CD3-binding antibodies
Read More
Rockefeller University presents novel FXIIa inhibitors
Read More
University of California identifies new growth factors for bone regeneration
Read More
Aelin Therapeutics secures series A financing
Read More
Roche exercises option to license IONIS-HTTrx
Read More
Novel PD-1 signaling inhibitors presented by Incyte
Read More
Mereo BioPharma reports phase II results for acumapimod in COPD
Read More
FDA approves Sanofi's follow-on insulin product
Read More
Favorable initial results seen with INCB-057643 in patients with advanced cancer
Read More
PsiOxus receives milestone payment upon CTA approval for NG-348
Read More
Altimmune submits IND application for anthrax vaccine
Read More
Allergan to acquire Repros Therapeutics
Read More
Proteostasis reports data across three cystic fibrosis programs
Read More
Neurotransmitter alterations identified in novel model of ictogenesis
Read More
NIH supports new Alzheimer's Clinical Trial Consortium
Read More
NeuroVive reports interim results from phase I study of KL-1333
Read More
Almirall and Athenex to collaborate on developing KX2-391
Read More